Utilising pharmacogenomics to improve medication outcomes

+Practice
In print
Pharmacogenomics

Utilising pharmacogenomics to improve medication outcomes

By Katrina Azer
DNA_Helix
Response to some of the most commonly prescribed medications is impacted by genetic variation [Image: Nina Hill on Unsplash]

Pharmacogenomics is a promising field that helps tailor medications to genes. In this article, clinical pharmacist Katrina Azer reviews its impact on clinical practice and the challenges that need to be overcome to adopt it

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
References

1. National Institute of General Medical Sciences. Pharmacogenomics.

2. PharmGKB. www.pharmgkb.org

3. Swen JJ, van der Wouden CH, Manson LE, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet 2023;401(10374):347–56.

4. Connelly D. Pharmacogenomic testing pilot to start in general practice from June 2023. The Pharmaceutical Journal, 18 May 2023.

5. Arnone D, Omar O, Arora T, et al. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neurosci Biobehav Rev 2023;144:104965.

6. Krebs K, Milani L. Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good. Hum Genomics 2019;13(1):39.